01
How crowded it is
Nobody owns this audience. The 10 biggest advertisers run 17% of the ads, and 1,164 advertisers run just one. Most of what is live today went up in the last few weeks.
New ads every week
Ads still live today, by the week they launched. Ads that have already stopped don't appear, so earlier weeks read low. The last column is the week in progress.
Last full week (18 Oct)8,294new ads from 1,036 advertisers. 583 of them had no earlier ad still running.
02
People on GLP-1s are an audience, not a market
A search for "GLP-1" finds every ad that names the drug. The people those ads reach are also shopping for hair, gut, skin and menopause products, and the same brands follow them there.
Of the advertisers in each of these neighbouring searches, this share also run GLP-1 ads:
- Hair loss
- Menopause
- Creatine
- Protein powder
- Collagen
- Magnesium
Each neighbouring search is its first 1,000 live US ads in Meta's Ad Library, checked against the advertisers in our GLP-1 pull.
03
How crowded each need is
So we scored the audience one need at a time: the ads that speak to people on GLP-1s about each thing. Getting the drug is the most crowded at 88 out of 100. After the drug itself, keeping muscle is the busiest need at 80. Stopping the drug is the emptiest at 55: 177 advertisers and 2,215 ads.
| Need | Competition score | Advertisers | Live ads | Last 30 days | Top 10 hold |
|---|---|---|---|---|---|
| Getting the drugOnline prescribers and clinics selling the medication | 88 | 958 | 15,263 | 79% | 27% |
| Keeping muscleMuscle loss, protein, strength | 80 | 533 | 3,105 | 69% | 24% |
| Gut and constipationNausea, bloating, constipation, digestion | 78 | 574 | 6,751 | 56% | 36% |
| Skin and "Ozempic face"Loose skin, sagging, the face | 75 | 403 | 2,303 | 72% | 35% |
| Hair lossShedding and thinning on the drug | 74 | 313 | 2,472 | 72% | 32% |
| Menopause and hormonesWomen on GLP-1s in perimenopause or menopause | 69 | 385 | 3,726 | 56% | 51% |
| Stopping the drugComing off, regaining weight, keeping results | 55 | 177 | 2,215 | 41% | 62% |
The score is the average of four parts, each 0 to 100. Advertisers: 10 scores 0, 500 scores 100. Live ads: 100 scores 0, 10,000 scores 100 (both on a log scale). Last 30 days: the share itself. Top 10 hold: 100 minus their share. A need is matched from the ad's own words, and an ad can count towards several.
04
Who is advertising
We sorted every advertiser by what its ads sell, from the ad text and where the ad links. The two big groups barely overlap.
| Advertiser type | Advertisers | Ads | Share of ads |
|---|---|---|---|
| Online prescribers and telehealth | 698 | 17,346 | 49% |
| Supplements and other products | 1,028 | 12,908 | 36% |
| Local clinics and med spas | 116 | 434 | 1% |
| Clinical trials recruiting | 61 | 537 | 2% |
| Law firms | 41 | 186 | 1% |
| Apps | 31 | 236 | 1% |
| Food, coaching and fitness | 219 | 1,469 | 4% |
| Articles, price guides and news | 86 | 654 | 2% |
| Other or unclear | 802 | 1,989 | 6% |
| Advertiser | Type | Live ads | Launched in last 30 days |
|---|---|---|---|
| Join Embody | Online prescriber | 1,417 | 98% |
| Bioma.Health | Supplement or product | 727 | 31% |
| Blue Haven | Online prescriber | 713 | 83% |
| Friendly Health | Online prescriber | 643 | 32% |
| Mondae | Online prescriber | 619 | 100% |
| Natural Performance Institute | Online prescriber | 418 | 97% |
| TryEden | Online prescriber | 398 | 28% |
| Wellmedr | Online prescriber | 396 | 79% |
| ColonBroom | Supplement or product | 378 | 55% |
| Try AltRx | Online prescriber | 372 | 100% |
| Embody Cellular Health | Online prescriber | 371 | 100% |
| Dr Anna Poweld - Menopause Specialist | Supplement or product | 360 | 60% |
05
Market one: online prescribers, fighting on the bill
The drug is the same everywhere, so the ads compete on price. 55% of prescriber ads lead with a price or "no insurance needed", and 52% promise the price won't move: locked for life, the same at every dose, no hike after month one.
- 23% of prescriber ads sell compounded semaglutide or tirzepatide, the cheaper pharmacy-made versions.
- 34% sell the convenience: an online visit, no doctor's office, delivered to your door.
- Meta shows the images of these ads only to logged-in viewers. 82% of prescriber ads came back with text only, so the words are what we can study.
Most GLP-1 programs start cheap then jack up your price as your dose increases. We don't do that. Semaglutide: $149/mo Tirzepatide: $179/mo Your price stays locked. No surprise increases. No forced titration schedule. …
Compounded semaglutide from just $75/month ✅ Same price at every dose ✅ 100% online + free shipping ✅ No membership or hidden fees
From $69/month forever! Facts: Qualify in less than 2 mins for weight loss meds through Embody 🙌 No insurance needed, no in-person doctor's office, just a weight loss guarantee 👇 It’s one shot a week and you get personalized …
❌ No price hike after month 1. ❌ No subscription tricks. ❌ No membership fee. ❌ No auto-rebills. ❌ No games. Just transparent GLP-1 pricing: Tirzepatide: $179/mo All dosages. Same price. And unlike many brands that bury you in …
The big names run the same playbook: Hers, hims, Ro, WeightWatchers and GoodRx all lead with a monthly price.
06
Market two: selling to people already on the drug
Supplement brands rarely compete with the shot. They sell what comes after it: 43% of their ads talk about side effects like constipation and bloating, and others about hair, muscle and loose skin. 22% open as a first-person story.
Zepbound Took 62 Pounds. Then My Ponytail.Ad Library ↗
Made for GLP-1 ConstipationAd Library ↗
I lost 52 pounds. My arms stayed behind.Ad Library ↗
She Kept Her Muscle On GLP-1. Her Secret?Ad Library ↗
I hid my GLP-1 from my family then it stopped workingAd Library ↗
Lose the Fat. Keep the curves.Ad Library ↗
Skip The Shot. Keep The Results.Ad Library ↗
☀️ Summer Sale: 35% Off Bioma GLP-1 BoosterAd Library ↗
- The same story often runs under many different names. We found 223 story openings used word for word by three or more different Pages, across 7,912 ads.
- 25% pitch a "natural" alternative or a "GLP-1 booster". 33% offer pills, drops or patches instead of injections.
07
What each market talks about
The share of ads that mention each theme. Prescribers talk about price and access. Supplement brands talk about the body.
| Theme in the ad | All ads | Prescribers | Supplements |
|---|---|---|---|
| A price, or no insurance needed | 37% | 55% | 25% |
| A doctor or clinician | 36% | 48% | 27% |
| A locked price: same at every dose, no hikes | 27% | 52% | 3% |
| Side effects: nausea, gut, constipation | 22% | 8% | 43% |
| Food, meals, food noise | 21% | 10% | 39% |
| Prescribed online, from home | 18% | 34% | 3% |
| Pills, drops, patches instead of injections | 16% | 7% | 33% |
| A natural alternative or "GLP-1 booster" | 12% | 4% | 25% |
| Compounded versions | 11% | 23% | 1% |
| A first-person story | 11% | 4% | 22% |
| Menopause and hormones | 11% | 3% | 23% |
| Keeping muscle, protein | 9% | 4% | 14% |
| Hair loss | 7% | 1% | 13% |
| Skin, "Ozempic face" | 7% | 1% | 13% |
| Stopping the drug, keeping the weight off | 6% | 1% | 15% |
Themes are matched from the ad's own words. An ad can mention several.
08
Where there's still room
Life after the drug
2,215 ads, 6% of the total, talk to people stopping the drug or trying to keep the weight off, a moment most of these customers reach. Only 177 advertisers do it, the ten biggest run 62% of those ads, and only 41% launched in the last 30 days.
New buyers in the auction
41 law firms recruit for lawsuits over vision loss and stomach problems, 61 research sites recruit for trials, and Kroger's pharmacies run GLP-1 ads under Ralphs, Fry's, King Soopers and Smith's.
Ozempic / Wegovy NAION HelplineAd Library ↗
The Ozempic Blindness News Missed ThisAd Library ↗
personalized GLP-1 support.Ad Library ↗
09
How we did this
On 28 October 2026 we searched Meta's Ad Library for active ads shown in the US that mention GLP-1, Ozempic, Wegovy, semaglutide, tirzepatide, Mounjaro or Zepbound, and read every result we were given: 35,759 different ads. Meta's own counts are higher (50,000+ for "GLP-1" alone), so treat our advertiser and ad counts as a floor.
Advertiser types and themes come from each ad's text and the page it links to, checked by hand for the 80 biggest advertisers. They are approximate. Launch dates are Meta's. We can see what ads say and how long they run, not how much anyone spends or what sells.
- Meta Ad Library ↗ Active ads shown in the US, collected 28 October 2026. Ads shown are public and belong to their advertisers.
The numbers behind this page: glp-1-meta.json
Run this on your market
Flixr Studio reads every ad in a market and shows who is targeting your audience, with what message, and where nobody is.